EUCTR2004-002759-15-ES进行中（未招募）不适用
Randommized Phase II study of the continuous treatment vs. standard treatment with capecitabine in metastatic breast cancer patients
Dr. Miguel Martín0 个研究点开始时间: 2005年5月17日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- Female
入选标准
- •-Metastatic Breast Cancer diagnosed patients.
- •-Patients pretreated or not pretreated with antracyclines and/or taxanes (in adjuvance or in metastatic disease)
- •-Ambulatory patients with ang ECOG performance Status < or = 2
- •-To have at least a measurable injury in agreement with RECIST criteria
- •-To have a life expectancy = 3 months or more.
- •-Patients being able to comply with the protocol requirements during the study performance.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •-Pacients with episodes of non expected severe reactions due to the fluoropirimidin therapy, or with known sensitivity caused by 5-fluorouracil
- •-Pretreated patients with Capecitabine
- •-Patients with organ graft
- •-Severe diseases
- •-Central Nervous System metastasis
研究者
相似试验
尚未招募
不适用
Randomized Phase II study regarding treatment cycles of neo-adjuvant chemotherapy with biweekly triplet gemcitabine/cisplatin/s-1 for biliary tract cancerResectable Biliary Tract CancersJPRN-UMIN000036542KHBO100
进行中（未招募）
不适用
Estudio Fase II no aleatorizado de tratamiento con Temozolamida combinada con Topotecan para neuroblastoma y otros tumores sólidos pediátricos en situación de recaída o progresión. Phase 2 single-arm studies of Temozolamide incombination with Topotecan in refractory and relapsed neuroblastoma and other paediatric solid tumourseuroblastoma, tumores cerebrales diferentes al meduloblastoma u otros tumores sólidos diversos en población pediátrica (de 6 meses a 20 años).EUCTR2008-001436-12-ESFUNDACION PARA LA INVESTIGACION LA FE96
进行中（未招募）
1 期
A Clinical trial to Breast Cancer where two different ways to give the chemotherapy capsules are comparedEUCTR2011-003564-72-DKAarhus University Hospital110
进行中（未招募）
1 期
on-randomised phase II trial of Sequential Therapy of Imiquimod followed by Vaccination with TA CIN for High Grade VIVIN3EUCTR2005-001824-35-GBniversity of Manchester30
已完成
不适用
Continuous administration trial of Phase2 Study of OCV-101 in Combination With Gemcitabine in Patients With Unresectable Advanced Pancreatic Cancer and Recurrent Pancreatic Cancernresectable Advanced and Recurrent Pancreatic cancerJPRN-UMIN000009085OncoTherapy Science, Inc.2